Weiss Ratings reaffirmed their sell (e+) rating on shares of 111 (NASDAQ:YI – Free Report) in a research note released on Saturday morning,Weiss Ratings reports.
111 Trading Up 13.2 %
NASDAQ:YI opened at $6.59 on Friday. The company’s 50-day moving average price is $6.58 and its 200-day moving average price is $7.74. 111 has a twelve month low of $4.14 and a twelve month high of $15.80. The company has a market cap of $56.34 million, a P/E ratio of -1.65 and a beta of 0.41.
111 (NASDAQ:YI – Get Free Report) last issued its earnings results on Wednesday, November 27th. The company reported ($0.20) EPS for the quarter.
111 Company Profile
111, Inc engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through the B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies.
Featured Articles
- Five stocks we like better than 111
- What is the Dow Jones Industrial Average (DJIA)?
- How to Invest in Small Cap Stocks
- Financial Services Stocks Investing
- These Are the Dividend Stocks Insiders Bought in January
- What Are Dividend Contenders? Investing in Dividend Contenders
- How the ‘No Buy’ Trend of 2025 Is Boosting These 3 Stocks
Receive News & Ratings for 111 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 111 and related companies with MarketBeat.com's FREE daily email newsletter.
